Aberrant glycosylation is a feature of cancer cells. The abnormally expressed cell surface glycoproteins or glycolipids may contribute to many aspects of the malignant phenotype. These tumor associated antigens are pr...
详细信息
Aberrant glycosylation is a feature of cancer cells. The abnormally expressed cell surface glycoproteins or glycolipids may contribute to many aspects of the malignant phenotype. These tumor associated antigens are preferred targets for cancer immunotherapy. Immunotherapy targeting two glycolipid antigens, GD2 and Globo H will be discussed. GD2 is highly expressed in neuroblastoma,
暂无评论